Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé
⟶ France’s Erytech has forged a collaboration with Queen’s University in Canada on their eryminase program specifically for the treatment of arginase-1 deficiency, a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
